Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 17.50
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
BKY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berkeley signs US$120 million strategic investment

30 Aug 2017 07:04

RNS Number : 2636P
Berkeley Energia Limited
30 August 2017
 

BERKELEY ENERGIA LIMITED

NEWS RELEASE | 30 August 2017 | AIM/ASX: BKY

Berkeley Energia signs US$120 million sovereign wealth fund strategic investment to bring Salamanca into production

Berkeley Energia ("Company") is pleased to announce that it has entered into an investment agreement with the sovereign wealth fund of the Sultanate of Oman agreeing to invest up to US$120 million to fully fund the Salamanca mine into production.

The investment will position the fund as a long term strategic investor in the Company as well as a potential offtake partner, and is structured as:

· an interest-free and unsecured convertible loan of US$65 million which can be converted into ordinary shares at 50 pence per share resulting in the fund owning approximately 28% of the Company; and,

· three tranches of options convertible at a weighted average price of 85 pence per share contributing a further US$55 million towards the later phases of the Company's development of the Salamanca mine resulting in the fund holding a further 9% of the Company.

The investment is binding on the parties and is subject to approval by the Company's shareholders.

The fund will have the right to appoint a non-executive director to the Board and has the right to match future uranium off-take transactions on similar commercial terms subject to certain limitations on volume. A summary of the key commercial terms of the investment by the State General Reserve Fund ("SGRF") is included below.

Managing Director, Paul Atherley, commented:

"We are delighted to welcome Oman's sovereign wealth fund as a long-term strategic investor in the Company and look forward to working closely with them to realise the full potential of the exciting Salamanca project.

The Salamanca mine is one of the only major uranium mines in development in the world today at a time when spot uranium prices are at a decade low.

The project benefits from a rare combination of low up front capital cost and very low operating costs and due in part to its location in the heart of the European Union we are able to contract supply at prices well above the current spot price.

The fund's interest in matching our future off-take contracts will further enhance our revenue stream."

Mr Tim Keating, Private Equity Manager for Mining and Resources, State General Reserve Fund commented:

"The Salamanca mine matches our investment criteria of being a long life, low cost mine development opportunity with outstanding economic fundamentals. We are excited to partner with the Berkeley Energia team to unlock the full potential of the Salamanca project."

Canaccord Genuity London acted as corporate finance advisor to the transaction.

For further information please contact:

Berkeley Energia Limited

+44 20 3903 1930

Paul Atherley, Managing Director

info@berkeleyenergia.com

Hugo Schumann, Chief Commercial Officer

 

 

 

Peel Hunt LLP (Joint Broker)

+44 20 7418 8900

Matthew Armitt

 

Ross Allister

 

Chris Burrows

 

 

 

WH Ireland Limited (Nominated Adviser)

+44 20 7220 1666

Paul Shackleton

 

Jessica Cave

 

 

 

Buchanan

+44 207 466 5000

Bobby Morse, Senior Partner

BKY@buchanan.uk.com

Anna Michniewicz, Account Director

 

 

KEY COMMERCIAL TERMS OF INVESTMENT BY SGRF

Subject to shareholder approval and other conditions precedent, the Company will place a US$65 million Convertible Loan Note ("Note") to SGRF. The Note is non-interest bearing and is unsecured and only repayable in an event of breach of the terms of the investment agreement which includes a breach of a representation or warranty, a breach of covenants, insolvency or the Company ceasing to conduct business or ceasing being listed on either AIM, LSE or ASX. The Note is convertible by SGRF at any time into fully paid ordinary shares of the Company at an issue price of £0.50 per share being an 11% premium to the 10 day volume weighted average price of Berkeley's shares on AIM to 29 August 2017. Should the Company raise further equity prior to conversion of the Note at a price below £0.50 then the conversion price of the Note will be reset to the issue price of the equity raising, subject to a floor price of £0.27 per share. The Company may convert all or part of the Note into ordinary shares in the Company any time after Technical Completion of the centralised processing plant at Retortillo has occurred. Technical Completion is defined to occur once key commissioning tests have been successfully completed. If Technical Completion has not occurred 4 years after the issue of the Note, then the Note will automatically convert into shares at the lower of £0.50 per share or the last trading price of the Company's shares on AIM at the relevant time, subject to conversion at the floor price of £0.27 per share. The Note may also be converted by either SGRF or the Company if a change of control event occurs in relation to the Company.

 

Upon receipt of shareholder approval and upon satisfaction of conditions precedent, the Company will also issue to SGRF a total of 50,443,124 unlisted options in three tranches for a further US$55 million once exercised as follows:

§ 10,088,625 options with an exercise price of £0.60, vesting and exercisable on Conversion of the Note and expiring 12 months from the date of vesting;

§ 15,132,937 options with an exercise price of £0.75, vesting and exercisable on Conversion of the Note and expiring 18 months from the date of vesting; and

§ 25,221,562 options with an exercise price of £1.00, vesting and exercisable on Conversion of the Note and expiring 24 months from the date of vesting.

 

The investment agreement also provides that if SGRF holds a 10% interest in the Company on an as-converted basis they have the right to appoint one nominee to the board of the Company and the right to be provided with certain information from the Company common for this type of investment.

 

The Company is also pleased to grant SGRF the right to purchase uranium from the Company at the same price and up to the same volume as any bone fide customer of the Company who concludes a future long-term offtake agreement with Company. The right to match shall be subject to an annual cap (on a rolling 12 month basis) on the volume of mined product, which shall not exceed the greater of 1 million pounds of U3O8 concentrate per annum or 20% of annual production. SGRF has 30 days to match off-take contracts following receipt of notice from the Company of entering into a new long-term offtake contract. Existing contracts in place will not be subject to the right to match provision. The right to match only applies so long as SGRF holds more than a 10% interest in the Company on an as-converted basis. If a change of control transaction occurs, the right to match shall cease to exist. The right to match transactions is subject to approval from Euratom and compliance with applicable laws and exchange rules.

 

The investment agreement with SGRF contains exclusivity provisions with no shop restriction, no talk restriction (subject to the Company's directors' fiduciary obligations) and a notification obligation in respect of potential competing transactions. The investment agreement also contains the usual warranties and undertakings considered standard for this type of investment. Conditions precedent of the transaction include the following: Berkeley shareholders approving the issue of ordinary shares and options to SGRF pursuant to the conversion of the Note, Foreign Investment Review Board's approval for SGRF's investment and other conditions precedent which are considered standard for an agreement of this nature including no material adverse change, no law or litigation prohibiting the transaction, representations and warranties of the parties being true and correct and the parties complying in all material respects with their obligations under the investment agreement. The investment agreement may be terminated if any conditions precedent are not satisfied or waived by 31 January 2018 and SGRF may terminate if there is a breach of a representation or warranty or a material adverse change occurs in respect of the Company. Subject to the opinion of the independent expert and the Company's directors' fiduciary obligations, each Board member intends to vote in favour of the transaction in respect of all ordinary shares they hold or control. Subject to the same qualification, each director unanimously recommends that shareholders vote in favour of the transaction at the shareholders meeting which will take place in due course.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGLGDIDGXBGRG
Date   Source Headline
30th Apr 20147:01 amRNSAppendix 5b
30th Apr 20147:00 amRNSMarch 2014 Quarterly Report
24th Apr 20147:00 amRNSMining licence granted for Retortillo
28th Mar 20148:31 amRNSPerformance Share Rights
13th Mar 20147:00 amRNSHalf Yearly Report
31st Jan 20148:09 amRNSAppendix 5b
31st Jan 20148:09 amRNSDecember Quarterly Report
3rd Jan 20143:48 pmRNSDisclosure of Directors' Appointments
3rd Jan 20143:41 pmRNSChange of Adviser
31st Dec 20137:00 amRNSIssue of Securities
20th Nov 20139:57 amRNSResult of AGM
31st Oct 20137:08 amRNSAppendix 5B
31st Oct 20137:08 amRNS1st Quarter Results
18th Oct 20139:35 amRNSNotice of AGM
8th Oct 201310:34 amRNSEnvironmental Licence
26th Sep 20137:33 amRNSPre-Feasibility Study
20th Sep 201310:01 amRNSAnnual Financial Report
7th Aug 20137:11 amRNSDrilling Report
30th Jul 20137:10 amRNSAppendix 5B
30th Jul 20137:10 amRNSQuarterly Report
20th May 20137:25 amRNSCompany Presentation
17th May 20138:25 amRNSBlocklisting Interim Review
17th May 20138:25 amRNSDirector/PDMR Shareholding
17th May 20138:22 amRNSIssue of Equity
3rd May 20137:42 amRNSAppendix 3Y 2 of 2
3rd May 20137:42 amRNSAppendix 3Y 1 of 2
3rd May 20137:40 amRNSAppendix 3B
29th Apr 20137:22 amRNS3rd Quarter Results
29th Apr 20137:22 amRNSAppendix 5B
16th Apr 20137:43 amRNSExpiry of Listed Options
12th Apr 20139:24 amRNSResult of Meeting
14th Mar 20137:39 amRNSHalf Yearly Report
12th Mar 20137:45 amRNSNotice of General Meeting
8th Feb 20138:41 amRNSHolding(s) in Company
31st Jan 20138:46 amRNSAppendix 5B - Mining exploration entity quarterly
31st Jan 20138:44 amRNSDecember 2012 Quarterly Report
29th Nov 20128:59 amRNSAppendix 3Z
29th Nov 20128:57 amRNSResult of AGM
29th Nov 20127:39 amRNSScoping Study
9th Nov 20127:30 amRNSAppendix 3B
7th Nov 20128:50 amRNSHolding(s) in Company
31st Oct 20128:04 amRNS1st Quarter Results
31st Oct 20127:50 amRNSAppendix 5B
26th Oct 20127:16 amRNSNotice of AGM
27th Sep 20128:45 amRNSFinal Results
14th Aug 20127:26 amRNSBlocklisting Interim Review
10th Aug 20127:24 amRNSAppendix 3B
8th Aug 20129:33 amRNSHolding(s) in Company
2nd Aug 20128:25 amRNSAppendix 3Z
2nd Aug 20128:24 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.